HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bizhan Malaekeh-Nikouei Selected Research

galbanic acid

7/2021The effect of RGD-targeted and non-targeted liposomal Galbanic acid on the therapeutic efficacy of pegylated liposomal doxorubicin: From liposomal preparation to in-vivo studies.
2/2020Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
1/2019Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bizhan Malaekeh-Nikouei Research Topics

Disease

17Neoplasms (Cancer)
03/2022 - 10/2011
4Dehydration (Water Stress)
09/2021 - 05/2009
3Carcinoma (Carcinomatosis)
02/2020 - 01/2015
2Endophthalmitis (Ophthalmia)
04/2020 - 05/2009
1Colorectal Neoplasms (Colorectal Cancer)
02/2022
1Infections
09/2021
1Colonic Neoplasms (Colon Cancer)
07/2021
1Heart Failure
08/2018
1Hypertension (High Blood Pressure)
08/2018
1Type 2 Diabetes Mellitus (MODY)
08/2018
1Cardiac Arrhythmias (Arrythmia)
08/2018
1Diarrhea
08/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Hyperthermia
05/2017
1Gingivitis
02/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1Pheochromocytoma
01/2015
1Postoperative Pain
09/2013
1Pain (Aches)
09/2013
1Inflammation (Inflammations)
06/2012
1Cataract (Cataracts)
05/2009
1Retinal Detachment (Retinal Detachments)
05/2009
1Vitreous Hemorrhage
05/2009

Drug/Important Bio-Agent (IBA)

6Liposomes (Liposome)IBA
01/2022 - 05/2009
5Pharmaceutical PreparationsIBA
01/2018 - 06/2012
5Silicon Dioxide (Silica)FDA LinkGeneric
01/2018 - 01/2015
4Epirubicin (Ellence)FDA LinkGeneric
06/2020 - 01/2015
3galbanic acidIBA
07/2021 - 01/2019
3liposomal doxorubicin (Doxil)FDA Link
07/2021 - 01/2019
2APTIBA
02/2022 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 04/2020
2coumarinIBA
07/2021 - 01/2019
2SesquiterpenesIBA
07/2021 - 01/2019
2Irinotecan (Camptosar)FDA LinkGeneric
06/2019 - 07/2016
2Small Interfering RNA (siRNA)IBA
01/2016 - 01/2016
1HydrogelsIBA
03/2022
1NucleolinIBA
02/2022
1AGRO 100IBA
02/2022
1Lipid NanoparticlesIBA
02/2022
1Docetaxel (Taxotere)FDA Link
02/2022
1PAMAM StarburstIBA
01/2022
1SolventsIBA
09/2021
1arginyl-glycyl-aspartic acidIBA
07/2021
1cyclo(arginylglycyl)IBA
07/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
06/2020
1Durapatite (Hydroxylapatite)IBA
06/2020
1VancomycinFDA LinkGeneric
04/2020
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
06/2019
1fosbretabulin (combretastatin A4)IBA
01/2019
1LigandsIBA
01/2019
11-dodecylpyridoxal (PLD)IBA
01/2019
1Adenosine Monophosphate (AMP)IBA
08/2018
1Glucose (Dextrose)FDA LinkGeneric
08/2018
1Protein Kinases (Protein Kinase)IBA
08/2018
1Therapeutic UsesIBA
08/2018
1PhytochemicalsIBA
08/2018
1LipidsIBA
08/2018
1AlkaloidsIBA
08/2018
1BerberineIBA
08/2018
1isoquinolineIBA
08/2018
1Plant Preparations (Preparation, Plant)IBA
02/2016
1ChlorhexidineIBA
02/2016
1MouthwashesIBA
02/2016
1EnzymesIBA
01/2015
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2015
1PolyethyleneimineIBA
01/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015
1safranalIBA
12/2013
1Analgesics (Analgesic Drugs)IBA
09/2013
1Diclofenac (SR 38)FDA LinkGeneric
09/2013
1crocinIBA
10/2011
1Bevacizumab (Avastin)FDA Link
05/2009

Therapy/Procedure

6Therapeutics
03/2022 - 01/2015
4Fluid Therapy (Oral Rehydration Therapy)
09/2021 - 05/2009
2Injections
03/2022 - 05/2009
2Drug Therapy (Chemotherapy)
01/2016 - 01/2015
1Photorefractive Keratectomy
09/2013
1Intravitreal Injections
05/2009